aromasil has been researched along with Nausea in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iwata, H; Kimura, R; Lee, MJ; Masuda, N; Nishimura, Y; Saji, S; Sawaki, M; Shimomura, A; Tamura, K; Trepel, J; Yasojima, H; Yuno, A | 1 |
| Abe, R; Andou, J; Aoyama, H; Fujita, Y; Higashi, Y; Hirata, K; Kajiwara, T; Kanda, K; Kashiki, Y; Kimura, M; Kinoshita, H; Kitajima, M; Kobayashi, T; Kobayashi, Z; Koyama, H; Koyanagi, Y; Miura, S; Miyazaki, I; Monden, M; Morishita, Y; Nagao, K; Nomura, Y; Ogita, M; Oka, T; Satomi, S; Sonoo, H; Tabei, T; Takai, S; Takashima, S; Takatsuka, Y; Toge, T; Tominaga, K; Toyama, K; Watanabe, M; Watanabe, T; Yamaguchi, S; Yayoi, E; Yoshino, K | 1 |
| de Belder, K; di Salle, E; Lanzalone, S; Lobelle, JP; Ornati, G; Paridaens, R; Polli, A; Thomas, J; Vermeiren, P; Wildiers, J; Zurlo, MG | 1 |
| Buzdar, A; Howell, A | 1 |
1 review(s) available for aromasil and Nausea
| Article | Year |
|---|---|
Advances in aromatase inhibition: clinical efficacy and tolerability in the treatment of breast cancer.
Topics: Anastrozole; Androstadienes; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Fadrozole; Female; Headache; Humans; Letrozole; Nausea; Nitriles; Treatment Outcome; Triazoles; Vomiting | 2001 |
3 trial(s) available for aromasil and Nausea
| Article | Year |
|---|---|
Phase 1 trial of entinostat as monotherapy and combined with exemestane in Japanese patients with hormone receptor-positive advanced breast cancer.
Topics: Acetylation; Aged; Androstadienes; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Benzamides; Breast Neoplasms; Female; Histone Deacetylase Inhibitors; Humans; Hypophosphatemia; Japan; Lymphocyte Activation; Middle Aged; Nausea; Platelet Count; Progression-Free Survival; Pyridines | 2021 |
[Early phase II dose-finding study of exemestane in postmenopausal patients with advanced/recurrent breast cancer].
Topics: Administration, Oral; Androstadienes; Antineoplastic Agents; Breast Neoplasms; Drug Administration Schedule; Estrogens; Female; Headache; Hot Flashes; Humans; Middle Aged; Nausea; Postmenopause; Receptors, Estrogen | 2002 |
Safety, activity and estrogen inhibition by exemestane in postmenopausal women with advanced breast cancer: a phase I study.
Topics: Adult; Aged; Androstadienes; Antineoplastic Agents; Breast Neoplasms; Dizziness; Dose-Response Relationship, Drug; Estrogen Antagonists; Estrogens; Female; Headache; Humans; Middle Aged; Nausea; Postmenopause | 1998 |